Gohealth Inc (GOCO) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The company's financial performance is significantly deteriorating, with sharp declines in revenue, net income, EPS, and gross margin. Technical indicators suggest a bearish trend, and there are no positive catalysts or trading signals to support a buy decision. Additionally, there is no recent news, analyst updates, or congressional trading data to provide a compelling reason to invest in this stock.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting an overall downward trend. Key support and resistance levels show limited upside potential, with resistance at 1.783 and support at 1.353.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The company's financial performance is extremely poor, with a 71.10% YoY revenue drop, a 2950.91% YoY decline in net income, and a gross margin of -27.56%. Additionally, stock trend analysis predicts a negative performance in the next week (-1.72%) and month (-5.96%).
In Q3 2025, the company reported a sharp decline in revenue (-71.10% YoY), net income (-2950.91% YoY), EPS (-2665.22% YoY), and gross margin (-143.42% YoY). These metrics indicate severe financial distress.
No recent analyst ratings or price target changes available.